Loading…

Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents

ABSTRACT Lung cancer is the second most prevalent cancer. Spinal metastases are found in 30–90% of patients with death attributed to cancer. Due to bony destruction caused by metastases, surgical intervention is often required to restore spinal alignment and stability. While some research suggests t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of orthopaedic research 2016-07, Vol.34 (7), p.1274-1281
Main Authors: Sonn, Kevin A., Kannan, Abhishek S., Bellary, Sharath S., Yun, Chawon, Hashmi, Sohaib Z., Nelson, John T., Ghodasra, Jason H., Nickoli, Michael S., Parimi, Vamsi, Ghosh, Anjan, Shawen, Nicholas, Ashtekar, Amruta, Stock, Stuart R., Hsu, Erin L., Hsu, Wellington K.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4689-7cf0ea3156c4b69991f43eb58cdc0fba530165c26aeb39056513970db07ed8b03
cites cdi_FETCH-LOGICAL-c4689-7cf0ea3156c4b69991f43eb58cdc0fba530165c26aeb39056513970db07ed8b03
container_end_page 1281
container_issue 7
container_start_page 1274
container_title Journal of orthopaedic research
container_volume 34
creator Sonn, Kevin A.
Kannan, Abhishek S.
Bellary, Sharath S.
Yun, Chawon
Hashmi, Sohaib Z.
Nelson, John T.
Ghodasra, Jason H.
Nickoli, Michael S.
Parimi, Vamsi
Ghosh, Anjan
Shawen, Nicholas
Ashtekar, Amruta
Stock, Stuart R.
Hsu, Erin L.
Hsu, Wellington K.
description ABSTRACT Lung cancer is the second most prevalent cancer. Spinal metastases are found in 30–90% of patients with death attributed to cancer. Due to bony destruction caused by metastases, surgical intervention is often required to restore spinal alignment and stability. While some research suggests that BMP‐2 may possess tumorigenic effects, other studies show possible inhibition of cancer growth. Thirty‐six athymic rats underwent intraosseous injection of lung adenocarcinoma cells into the L5 vertebral body. Cells were pre‐treated with vehicle control (Group A) or rhBMP‐2 (Group B) prior to implantation. At 4 weeks post‐implantation, in vivo bioluminescent imaging (BLI) was performed to confirm presence of tumor and quantify signal. Plain radiographs and microComputed Tomography (microCT) were employed to establish and quantitate osteolysis. Histological analysis characterized pathologic changes in the vertebral body. At 4 weeks post‐implantation, BLI showed focal signal in the L5 vertebral body in 93% of Group A animals and 89% of Group B animals. Average tumor burden by BLI radiance was 7.43 × 103 p/s/cm2/sr (Group A) and 1.11 × 104 p/s/cm2/sr (Group B). Radiographs and microCT demonstrated osteolysis in 100% of animals showing focal BLI signal. MicroCT demonstrated significant bone loss in both groups compared to age‐matched controls but no difference between study groups. Histological analysis confirmed tumor invasion in the L5 vertebral body. These findings provide a reliable in vivo model to study isolated spinal metastases from lung cancer. Statement of Clinical Significance: The data support the notion that exposure to rhBMP‐2 does not promote the growth of A549 lung cancer spine lesions. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1274–1281, 2016.
doi_str_mv 10.1002/jor.23139
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1805761058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1805761058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4689-7cf0ea3156c4b69991f43eb58cdc0fba530165c26aeb39056513970db07ed8b03</originalsourceid><addsrcrecordid>eNp1kE9v1DAQxS0EotvCgS-AfIRD2nEc28kRVWX5U7UILQJxsWxn0rok9tZOKP32uGzbG9JIMxr93tPMI-QVg0MGUB9dxXRYc8a7J2TFhGgqUasfT8kKFJcV1FLukf2crwBAsbp9TvbKqmtU063I9ckwoJtpHGhCFyfrgwkzvVwmE6iNAekU0_YyXmDA2Tu6TXFGH6qaxkANDfE3jnRcwgV1JjhMNG_9nQhnk0v5XPR9QXygqQxhzi_Is8GMGV_e9wPy7f3J5vhDdXq-_nj87rRyjWy7SrkB0HAmpGus7LqODQ1HK1rXOxisERyYFK6WBi3vQEhR_lfQW1DYtxb4AXmz8y0nXy-YZz357HAcTcC4ZM1aEEoyEG1B3-5Ql2LOCQe9TX4y6VYz0HcJ65Kw_pdwYV_f2y52wv6RfIi0AEc74MaPePt_J_3p_OuDZbVT-Dzjn0eFSb-0VFwJ_f1srdc1P_u5-bLRn_lfyvSVsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1805761058</pqid></control><display><type>article</type><title>Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Sonn, Kevin A. ; Kannan, Abhishek S. ; Bellary, Sharath S. ; Yun, Chawon ; Hashmi, Sohaib Z. ; Nelson, John T. ; Ghodasra, Jason H. ; Nickoli, Michael S. ; Parimi, Vamsi ; Ghosh, Anjan ; Shawen, Nicholas ; Ashtekar, Amruta ; Stock, Stuart R. ; Hsu, Erin L. ; Hsu, Wellington K.</creator><creatorcontrib>Sonn, Kevin A. ; Kannan, Abhishek S. ; Bellary, Sharath S. ; Yun, Chawon ; Hashmi, Sohaib Z. ; Nelson, John T. ; Ghodasra, Jason H. ; Nickoli, Michael S. ; Parimi, Vamsi ; Ghosh, Anjan ; Shawen, Nicholas ; Ashtekar, Amruta ; Stock, Stuart R. ; Hsu, Erin L. ; Hsu, Wellington K.</creatorcontrib><description>ABSTRACT Lung cancer is the second most prevalent cancer. Spinal metastases are found in 30–90% of patients with death attributed to cancer. Due to bony destruction caused by metastases, surgical intervention is often required to restore spinal alignment and stability. While some research suggests that BMP‐2 may possess tumorigenic effects, other studies show possible inhibition of cancer growth. Thirty‐six athymic rats underwent intraosseous injection of lung adenocarcinoma cells into the L5 vertebral body. Cells were pre‐treated with vehicle control (Group A) or rhBMP‐2 (Group B) prior to implantation. At 4 weeks post‐implantation, in vivo bioluminescent imaging (BLI) was performed to confirm presence of tumor and quantify signal. Plain radiographs and microComputed Tomography (microCT) were employed to establish and quantitate osteolysis. Histological analysis characterized pathologic changes in the vertebral body. At 4 weeks post‐implantation, BLI showed focal signal in the L5 vertebral body in 93% of Group A animals and 89% of Group B animals. Average tumor burden by BLI radiance was 7.43 × 103 p/s/cm2/sr (Group A) and 1.11 × 104 p/s/cm2/sr (Group B). Radiographs and microCT demonstrated osteolysis in 100% of animals showing focal BLI signal. MicroCT demonstrated significant bone loss in both groups compared to age‐matched controls but no difference between study groups. Histological analysis confirmed tumor invasion in the L5 vertebral body. These findings provide a reliable in vivo model to study isolated spinal metastases from lung cancer. Statement of Clinical Significance: The data support the notion that exposure to rhBMP‐2 does not promote the growth of A549 lung cancer spine lesions. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1274–1281, 2016.</description><identifier>ISSN: 0736-0266</identifier><identifier>EISSN: 1554-527X</identifier><identifier>DOI: 10.1002/jor.23139</identifier><identifier>PMID: 26694749</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>A549 Cells ; Adenocarcinoma - pathology ; Adenocarcinoma of Lung ; Animals ; BMP-2 ; Bone Morphogenetic Protein 2 - adverse effects ; Humans ; Lumbar Vertebrae - pathology ; Luminescent Measurements ; lung cancer ; Lung Neoplasms - pathology ; Osteolysis - etiology ; Random Allocation ; Rats, Nude ; Recombinant Proteins ; Spinal Neoplasms - chemically induced ; Spinal Neoplasms - complications ; Spinal Neoplasms - secondary ; spine metastases</subject><ispartof>Journal of orthopaedic research, 2016-07, Vol.34 (7), p.1274-1281</ispartof><rights>2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4689-7cf0ea3156c4b69991f43eb58cdc0fba530165c26aeb39056513970db07ed8b03</citedby><cites>FETCH-LOGICAL-c4689-7cf0ea3156c4b69991f43eb58cdc0fba530165c26aeb39056513970db07ed8b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26694749$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sonn, Kevin A.</creatorcontrib><creatorcontrib>Kannan, Abhishek S.</creatorcontrib><creatorcontrib>Bellary, Sharath S.</creatorcontrib><creatorcontrib>Yun, Chawon</creatorcontrib><creatorcontrib>Hashmi, Sohaib Z.</creatorcontrib><creatorcontrib>Nelson, John T.</creatorcontrib><creatorcontrib>Ghodasra, Jason H.</creatorcontrib><creatorcontrib>Nickoli, Michael S.</creatorcontrib><creatorcontrib>Parimi, Vamsi</creatorcontrib><creatorcontrib>Ghosh, Anjan</creatorcontrib><creatorcontrib>Shawen, Nicholas</creatorcontrib><creatorcontrib>Ashtekar, Amruta</creatorcontrib><creatorcontrib>Stock, Stuart R.</creatorcontrib><creatorcontrib>Hsu, Erin L.</creatorcontrib><creatorcontrib>Hsu, Wellington K.</creatorcontrib><title>Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents</title><title>Journal of orthopaedic research</title><addtitle>J. Orthop. Res</addtitle><description>ABSTRACT Lung cancer is the second most prevalent cancer. Spinal metastases are found in 30–90% of patients with death attributed to cancer. Due to bony destruction caused by metastases, surgical intervention is often required to restore spinal alignment and stability. While some research suggests that BMP‐2 may possess tumorigenic effects, other studies show possible inhibition of cancer growth. Thirty‐six athymic rats underwent intraosseous injection of lung adenocarcinoma cells into the L5 vertebral body. Cells were pre‐treated with vehicle control (Group A) or rhBMP‐2 (Group B) prior to implantation. At 4 weeks post‐implantation, in vivo bioluminescent imaging (BLI) was performed to confirm presence of tumor and quantify signal. Plain radiographs and microComputed Tomography (microCT) were employed to establish and quantitate osteolysis. Histological analysis characterized pathologic changes in the vertebral body. At 4 weeks post‐implantation, BLI showed focal signal in the L5 vertebral body in 93% of Group A animals and 89% of Group B animals. Average tumor burden by BLI radiance was 7.43 × 103 p/s/cm2/sr (Group A) and 1.11 × 104 p/s/cm2/sr (Group B). Radiographs and microCT demonstrated osteolysis in 100% of animals showing focal BLI signal. MicroCT demonstrated significant bone loss in both groups compared to age‐matched controls but no difference between study groups. Histological analysis confirmed tumor invasion in the L5 vertebral body. These findings provide a reliable in vivo model to study isolated spinal metastases from lung cancer. Statement of Clinical Significance: The data support the notion that exposure to rhBMP‐2 does not promote the growth of A549 lung cancer spine lesions. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1274–1281, 2016.</description><subject>A549 Cells</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma of Lung</subject><subject>Animals</subject><subject>BMP-2</subject><subject>Bone Morphogenetic Protein 2 - adverse effects</subject><subject>Humans</subject><subject>Lumbar Vertebrae - pathology</subject><subject>Luminescent Measurements</subject><subject>lung cancer</subject><subject>Lung Neoplasms - pathology</subject><subject>Osteolysis - etiology</subject><subject>Random Allocation</subject><subject>Rats, Nude</subject><subject>Recombinant Proteins</subject><subject>Spinal Neoplasms - chemically induced</subject><subject>Spinal Neoplasms - complications</subject><subject>Spinal Neoplasms - secondary</subject><subject>spine metastases</subject><issn>0736-0266</issn><issn>1554-527X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kE9v1DAQxS0EotvCgS-AfIRD2nEc28kRVWX5U7UILQJxsWxn0rok9tZOKP32uGzbG9JIMxr93tPMI-QVg0MGUB9dxXRYc8a7J2TFhGgqUasfT8kKFJcV1FLukf2crwBAsbp9TvbKqmtU063I9ckwoJtpHGhCFyfrgwkzvVwmE6iNAekU0_YyXmDA2Tu6TXFGH6qaxkANDfE3jnRcwgV1JjhMNG_9nQhnk0v5XPR9QXygqQxhzi_Is8GMGV_e9wPy7f3J5vhDdXq-_nj87rRyjWy7SrkB0HAmpGus7LqODQ1HK1rXOxisERyYFK6WBi3vQEhR_lfQW1DYtxb4AXmz8y0nXy-YZz357HAcTcC4ZM1aEEoyEG1B3-5Ql2LOCQe9TX4y6VYz0HcJ65Kw_pdwYV_f2y52wv6RfIi0AEc74MaPePt_J_3p_OuDZbVT-Dzjn0eFSb-0VFwJ_f1srdc1P_u5-bLRn_lfyvSVsg</recordid><startdate>201607</startdate><enddate>201607</enddate><creator>Sonn, Kevin A.</creator><creator>Kannan, Abhishek S.</creator><creator>Bellary, Sharath S.</creator><creator>Yun, Chawon</creator><creator>Hashmi, Sohaib Z.</creator><creator>Nelson, John T.</creator><creator>Ghodasra, Jason H.</creator><creator>Nickoli, Michael S.</creator><creator>Parimi, Vamsi</creator><creator>Ghosh, Anjan</creator><creator>Shawen, Nicholas</creator><creator>Ashtekar, Amruta</creator><creator>Stock, Stuart R.</creator><creator>Hsu, Erin L.</creator><creator>Hsu, Wellington K.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201607</creationdate><title>Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents</title><author>Sonn, Kevin A. ; Kannan, Abhishek S. ; Bellary, Sharath S. ; Yun, Chawon ; Hashmi, Sohaib Z. ; Nelson, John T. ; Ghodasra, Jason H. ; Nickoli, Michael S. ; Parimi, Vamsi ; Ghosh, Anjan ; Shawen, Nicholas ; Ashtekar, Amruta ; Stock, Stuart R. ; Hsu, Erin L. ; Hsu, Wellington K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4689-7cf0ea3156c4b69991f43eb58cdc0fba530165c26aeb39056513970db07ed8b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>A549 Cells</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma of Lung</topic><topic>Animals</topic><topic>BMP-2</topic><topic>Bone Morphogenetic Protein 2 - adverse effects</topic><topic>Humans</topic><topic>Lumbar Vertebrae - pathology</topic><topic>Luminescent Measurements</topic><topic>lung cancer</topic><topic>Lung Neoplasms - pathology</topic><topic>Osteolysis - etiology</topic><topic>Random Allocation</topic><topic>Rats, Nude</topic><topic>Recombinant Proteins</topic><topic>Spinal Neoplasms - chemically induced</topic><topic>Spinal Neoplasms - complications</topic><topic>Spinal Neoplasms - secondary</topic><topic>spine metastases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sonn, Kevin A.</creatorcontrib><creatorcontrib>Kannan, Abhishek S.</creatorcontrib><creatorcontrib>Bellary, Sharath S.</creatorcontrib><creatorcontrib>Yun, Chawon</creatorcontrib><creatorcontrib>Hashmi, Sohaib Z.</creatorcontrib><creatorcontrib>Nelson, John T.</creatorcontrib><creatorcontrib>Ghodasra, Jason H.</creatorcontrib><creatorcontrib>Nickoli, Michael S.</creatorcontrib><creatorcontrib>Parimi, Vamsi</creatorcontrib><creatorcontrib>Ghosh, Anjan</creatorcontrib><creatorcontrib>Shawen, Nicholas</creatorcontrib><creatorcontrib>Ashtekar, Amruta</creatorcontrib><creatorcontrib>Stock, Stuart R.</creatorcontrib><creatorcontrib>Hsu, Erin L.</creatorcontrib><creatorcontrib>Hsu, Wellington K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of orthopaedic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sonn, Kevin A.</au><au>Kannan, Abhishek S.</au><au>Bellary, Sharath S.</au><au>Yun, Chawon</au><au>Hashmi, Sohaib Z.</au><au>Nelson, John T.</au><au>Ghodasra, Jason H.</au><au>Nickoli, Michael S.</au><au>Parimi, Vamsi</au><au>Ghosh, Anjan</au><au>Shawen, Nicholas</au><au>Ashtekar, Amruta</au><au>Stock, Stuart R.</au><au>Hsu, Erin L.</au><au>Hsu, Wellington K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents</atitle><jtitle>Journal of orthopaedic research</jtitle><addtitle>J. Orthop. Res</addtitle><date>2016-07</date><risdate>2016</risdate><volume>34</volume><issue>7</issue><spage>1274</spage><epage>1281</epage><pages>1274-1281</pages><issn>0736-0266</issn><eissn>1554-527X</eissn><abstract>ABSTRACT Lung cancer is the second most prevalent cancer. Spinal metastases are found in 30–90% of patients with death attributed to cancer. Due to bony destruction caused by metastases, surgical intervention is often required to restore spinal alignment and stability. While some research suggests that BMP‐2 may possess tumorigenic effects, other studies show possible inhibition of cancer growth. Thirty‐six athymic rats underwent intraosseous injection of lung adenocarcinoma cells into the L5 vertebral body. Cells were pre‐treated with vehicle control (Group A) or rhBMP‐2 (Group B) prior to implantation. At 4 weeks post‐implantation, in vivo bioluminescent imaging (BLI) was performed to confirm presence of tumor and quantify signal. Plain radiographs and microComputed Tomography (microCT) were employed to establish and quantitate osteolysis. Histological analysis characterized pathologic changes in the vertebral body. At 4 weeks post‐implantation, BLI showed focal signal in the L5 vertebral body in 93% of Group A animals and 89% of Group B animals. Average tumor burden by BLI radiance was 7.43 × 103 p/s/cm2/sr (Group A) and 1.11 × 104 p/s/cm2/sr (Group B). Radiographs and microCT demonstrated osteolysis in 100% of animals showing focal BLI signal. MicroCT demonstrated significant bone loss in both groups compared to age‐matched controls but no difference between study groups. Histological analysis confirmed tumor invasion in the L5 vertebral body. These findings provide a reliable in vivo model to study isolated spinal metastases from lung cancer. Statement of Clinical Significance: The data support the notion that exposure to rhBMP‐2 does not promote the growth of A549 lung cancer spine lesions. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1274–1281, 2016.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26694749</pmid><doi>10.1002/jor.23139</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0736-0266
ispartof Journal of orthopaedic research, 2016-07, Vol.34 (7), p.1274-1281
issn 0736-0266
1554-527X
language eng
recordid cdi_proquest_miscellaneous_1805761058
source Wiley-Blackwell Read & Publish Collection
subjects A549 Cells
Adenocarcinoma - pathology
Adenocarcinoma of Lung
Animals
BMP-2
Bone Morphogenetic Protein 2 - adverse effects
Humans
Lumbar Vertebrae - pathology
Luminescent Measurements
lung cancer
Lung Neoplasms - pathology
Osteolysis - etiology
Random Allocation
Rats, Nude
Recombinant Proteins
Spinal Neoplasms - chemically induced
Spinal Neoplasms - complications
Spinal Neoplasms - secondary
spine metastases
title Effect of recombinant human bone morphogenetic protein-2 on a novel lung cancer spine metastasis model in rodents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A38%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20recombinant%20human%20bone%20morphogenetic%20protein-2%20on%20a%20novel%20lung%20cancer%20spine%20metastasis%20model%20in%20rodents&rft.jtitle=Journal%20of%20orthopaedic%20research&rft.au=Sonn,%20Kevin%20A.&rft.date=2016-07&rft.volume=34&rft.issue=7&rft.spage=1274&rft.epage=1281&rft.pages=1274-1281&rft.issn=0736-0266&rft.eissn=1554-527X&rft_id=info:doi/10.1002/jor.23139&rft_dat=%3Cproquest_cross%3E1805761058%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4689-7cf0ea3156c4b69991f43eb58cdc0fba530165c26aeb39056513970db07ed8b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1805761058&rft_id=info:pmid/26694749&rfr_iscdi=true